TRIAMCINOLONE

Post-LOE

triamcinolone

Teva

ANDAORALTABLET

Approved

Apr 1975

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

2/8 — Basic

Drug data last refreshed 1w ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (20)

NCT05336968Phase 4Recruiting

Triamcinolone Ketorolac (TriKe) Knee Trial

Started Sep 2022

150 enrolled

Osteoarthritis, Knee

NCT04841343N/ACompleted

Triamcinolone Packing Following Endoscopic Sinus Surgery

Started Jan 2021

22 enrolled

Sinusitis

NCT04598542Phase 1Completed

Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers

Started Oct 2020

40 enrolled

Drug-Drug Interaction

NCT04231318Phase 3Completed

Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain

Started Sep 2020

231 enrolled

Osteoarthritis, Knee

NCT03361176Phase 4Completed

Kybella With Triamcinolone

Started Mar 2018

30 enrolled

Adiposity

Worked on TRIAMCINOLONE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.